According to OncoCyte
's latest financial reports the company has a price-to-book ratio of 0.8806.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.5498 | -50.48% |
2022-12-31 | 1.11 | -63.82% |
2021-12-31 | 3.07 | -36.07% |
2020-12-31 | 4.80 | 15.36% |
2019-12-31 | 4.16 | -74.62% |
2018-12-31 | 16.4 | -50.61% |
2017-12-31 | 33.2 | 61.72% |
2016-12-31 | 20.5 | 34.72% |
2015-12-31 | 15.2 | |
2014-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | 175.53% | ๐บ๐ธ USA |